USRM Reaches Key Sales Milestone of Proprietary Adipocell(TM) Product

Company Poised to Be Industry Leader in Autologous Adipose Stem Cell Treatments SUNRISE, Fla., Jan. 15, 2018 -- (Healthcare Sales & Marketing Network) -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem... Regenerative Medicine U.S. Stem Cell, Adipocell, stem cell
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news